Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release - \Indian drug regulator grants marketing authorization to Wockhardt's breakthrough antibiotic , ZAYNICH (Zidebactum/ Cefepime), for treatment of complicated urinary tract infections including pyelonephritis with concurrent Gram- negative bacteremia\